Barts Health Nhs Trust
π¬π§United Kingdom
- Country
- π¬π§United Kingdom
- Ownership
- Private
- Employees
- -
- Market Cap
- -
Same-day Cardiac Surgery Cancellation
Completed
- Conditions
- Surgery
- First Posted Date
- 2020-05-13
- Last Posted Date
- 2020-05-13
- Lead Sponsor
- St. Bartholomew's Hospital
- Target Recruit Count
- 1388
- Registration Number
- NCT04386733
- Locations
- π¬π§
St Bartholomew's Hospital, London, United Kingdom
Epoetin Alfa or Epoetin Beta With or Without Iron Infusion in Treating Anemia in Patients With Cancer
Phase 3
- Conditions
- AnemiaLeukemiaLymphomaMultiple Myeloma and Plasma Cell NeoplasmUnspecified Adult Solid Tumor, Protocol Specific
- First Posted Date
- 2007-06-05
- Last Posted Date
- 2014-01-10
- Lead Sponsor
- St. Bartholomew's Hospital
- Target Recruit Count
- 80
- Registration Number
- NCT00482716
- Locations
- π¬π§
Saint Bartholomew's Hospital, London, England, United Kingdom
Early Diagnosis of Aspergillosis in Patients at High Risk of Fungal Infection Caused by Treatment for Hematologic Cancer or Other Disease
Not Applicable
- Conditions
- Graft Versus Host DiseaseInfectionLeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
- First Posted Date
- 2007-04-19
- Last Posted Date
- 2013-08-26
- Lead Sponsor
- St. Bartholomew's Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT00462657
- Locations
- π¬π§
Saint Bartholomew's Hospital, London, England, United Kingdom
π¬π§Royal Brompton Hospital, London, England, United Kingdom
Cyproterone Acetate in Treating Patients With Newly Diagnosed Stage III or Stage IV Prostate Cancer
Phase 3
- Conditions
- Prostate Cancer
- First Posted Date
- 2006-08-15
- Last Posted Date
- 2013-08-26
- Lead Sponsor
- St. Bartholomew's Hospital
- Target Recruit Count
- 900
- Registration Number
- NCT00363285
- Locations
- π¬π§
Saint Bartholomew's Hospital, London, England, United Kingdom
π¬π§Scarborough General Hospital, Scarborough, England, United Kingdom
Dexamethasone, Aspirin, and Diethylstilbestrol in Treating Patients With Locally Advanced or Metastatic Prostate Cancer
Phase 3
Completed
- Conditions
- Prostate Cancer
- First Posted Date
- 2006-04-21
- Last Posted Date
- 2013-06-26
- Lead Sponsor
- St. Bartholomew's Hospital
- Target Recruit Count
- 260
- Registration Number
- NCT00316927
- Locations
- π¬π§
Bristol Haematology and Oncology Centre, Bristol, England, United Kingdom
π¬π§Burnley General Hospital, Burnley, England, United Kingdom
π¬π§Kent and Canterbury Hospital, Canterbury, England, United Kingdom
Erythropoietin (EPO) and Granulocyte-Colony Stimulating Factor (G-CSF) for Low-Risk Myelodysplastic Syndromes (MDS)
Phase 2
- Conditions
- Myelodysplastic Syndromes
- Interventions
- Behavioral: Darbepoetin and Filgrastim
- First Posted Date
- 2005-10-06
- Last Posted Date
- 2009-03-12
- Lead Sponsor
- St. Bartholomew's Hospital
- Target Recruit Count
- 360
- Registration Number
- NCT00234143
- Locations
- π¬π§
St Bartholomew's Hospital, London, United Kingdom